Michael Schmidt - Guggenheim Analyst Performance This page shows the methodology used to calculate Michael Schmidt's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the analyst, and the stock's actual price 12 months from the date the research note was issued. These rankings are based on research reports from . Rankings are updated daily. MarketBeat Analyst Ranking: Subscribe to MarketBeat All Access for the recommendation accuracy ratingAverage 12-Month ROI of Buy and Strong Buy Recommendations: ???% Export to Excel CompanyReport DateReport Date Price12-MonthPrice TargetRating12-MonthActual Price12-MonthROIDetailsIMNMImmunome8/25/2025$10.49$25.00Buy???%???%MRSNMersana Therapeutics8/14/2025$6.96$30.00Buy???%???%ADCTADC Therapeutics8/13/2025$3.08$10.00Buy???%???%ORICOric Pharmaceuticals8/13/2025$10.01$18.00Buy???%???%CMPXCompass Therapeutics8/12/2025$3.34$12.00Buy???%???%ONCBeOne Medicines8/7/2025$296.33$365.00Buy???%???%ARVNArvinas8/7/2025$6.19$15.00Buy???%???%TNGXTango Therapeutics8/6/2025$6.35$10.00Buy???%???%COGTCogent Biosciences7/8/2025$9.16$17.00Buy???%???%RVMDRevolution Medicines6/25/2025$39.18$80.00Buy???%???%ADCTADC Therapeutics6/13/2025$3.77$10.00Buy???%???%KYMRKymera Therapeutics6/3/2025$49.69$60.00Buy???%???%URGNUrogen Pharma5/23/2025$3.93$15.00Buy???%???%MRSNMersana Therapeutics5/16/2025$8.20$125.00Buy???%???%EXELExelixis5/15/2025$45.40$45.00Buy???%???%ERASErasca5/14/2025$1.29$3.00Buy???%???%KYMRKymera Therapeutics5/12/2025$31.92$52.00Buy???%???%RVMDRevolution Medicines5/8/2025$42.50$80.00Buy???%???%ONCBeOne Medicines5/8/2025$233.78$350.00Buy???%???%RLAYRelay Therapeutics5/7/2025$3.03$10.00Buy???%???%SNDXSyndax Pharmaceuticals5/6/2025$12.16$32.00Buy???%???%ARVNArvinas5/2/2025$7.00$16.00Buy???%???%SWTXSpringWorks Therapeutics4/28/2025$46.18$47.00Neutral???%???%ONCBeOne Medicines4/16/2025$234.88Buy???%???%ONCBeOne Medicines4/10/2025$211.15$348.00Buy???%???%NBTXNanobiotix4/4/2025$3.27$8.00Buy???%???%ADCTADC Therapeutics3/31/2025$1.34$7.00Buy???%???%MRUSMerus3/28/2025$44.63$109.00Buy???%???%ADAPAdaptimmune Therapeutics3/26/2025$0.25$1.75Buy???%???%IMNMImmunome3/20/2025$8.47$25.00Buy???%???%MRUSMerus3/18/2025$46.94$109.00Buy???%???%INCYIncyte3/18/2025$62.01$92.00Neutral???%???%ARVNArvinas3/13/2025$8.52$32.00Buy???%???%LEGNLegend Biotech3/12/2025$37.63Neutral???%???%AVBPArriVent BioPharma3/10/2025$21.87$45.00Buy???%???%ORICOric Pharmaceuticals2/26/2025$8.69Buy???%???%CMPXCompass Therapeutics2/24/2025$2.92$12.00Buy???%???%ARVNArvinas2/12/2025$18.83$57.00Buy???%???%MRUSMerus2/12/2025$40.02Buy???%???%EXELExelixis2/12/2025$35.11$42.00Buy???%???%ORICOric Pharmaceuticals2/10/2025$12.25Buy???%???%IPSCCentury Therapeutics1/22/2025$0.90Buy???%???%EXELExelixis1/22/2025$33.97Buy???%???%ERASErasca1/3/2022$15.44$20.00???%???%IMRXImmuneering1/3/2022$17.00$30.00???%???%SGENSeagen5/1/2020$138.08Buy???%???%INCYIncyte1/2/2020$87.32Neutral???%???%BGNEBeiGene12/16/2019$170.75Neutral???%???%BGNEBeiGene11/15/2019$196.40$228.00Buy???%???%MRTXMirati Therapeutics11/5/2019$97.25$128.00Buy???%???%BGNEBeiGene11/1/2019$189.56$205.00Buy???%???%INCYIncyte9/27/2019$74.23$101.00Buy???%???%BLUEbluebird bio12/1/2016$1,373.00$1,700.00Outperform???%???%JUNOJuno Therapeutics11/28/2016$23.01$34.00Outperform???%???%INCYIncyte11/20/2016$103.63$115.00Outperform???%???%DRNADicerna Pharmaceuticals11/8/2016$3.01$8.00Buy???%???%BLUEbluebird bio11/7/2016$851.00$1,600.00Outperform???%???%INCYIncyte11/2/2016$87.19$101.00Outperform???%???%DAREDare Bioscience10/19/2016$8.17$18.00Market Perform???%???%BLUEbluebird bio10/14/2016$1,304.80$1,600.00Outperform???%???%INCYIncyte10/12/2016$92.11$98.00Outperform???%???%KPTIKaryopharm Therapeutics10/7/2016$143.40$270.00Outperform???%???%EXELExelixis10/7/2016$12.95$15.00Positive???%???%ALNYAlnylam Pharmaceuticals10/6/2016$70.30$40.00Market Perform???%???%INCYIncyte10/3/2016$94.29$98.00Outperform???%???%EXELExelixis9/28/2016$13.35$15.00Outperform???%???%JUNOJuno Therapeutics9/27/2016$29.65$45.00Outperform???%???%ALNYAlnylam Pharmaceuticals9/26/2016$75.57Buy???%???%ARRYArray Technologies9/26/2016$6.64$9.00Outperform???%???%EXELExelixis9/20/2016$13.64$12.00Outperform???%???%BLUEbluebird bio9/9/2016$57.51Buy???%???%EXELExelixis9/7/2016$12.08$12.00Positive???%???%ARRYArray Technologies8/30/2016$3.60$6.00Positive???%???%EXELExelixis8/29/2016$10.96$12.00Outperform???%???%QUREuniQure8/29/2016$8.49$27.00Outperform???%???%DAREDare Bioscience8/18/2016$32.88$18.00Market Perform???%???%EXELExelixis8/18/2016$10.62$12.00Outperform???%???%TRILTrillium Therapeutics8/15/2016$10.84$20.00Outperform???%???%AFMDAffimed8/12/2016$29.50$30.00Market Perform???%???%IONSIonis Pharmaceuticals8/11/2016$35.96$36.00Hold???%???%INCYIncyte8/10/2016$86.48$95.00Outperform???%???%FPRXFive Prime Therapeutics8/8/2016$52.44$58.00Outperform???%???%BLUEbluebird bio8/4/2016$1,076.20$1,340.00Outperform???%???%EXELExelixis8/4/2016$11.07$12.00Outperform???%???%IONSIonis Pharmaceuticals8/2/2016$38.01$36.00Market Perform???%???%QUREuniQure8/2/2016$7.37$27.00Positive???%???%ALNYAlnylam Pharmaceuticals7/19/2016$64.83Buy???%???%EXELExelixis7/19/2016$8.42$10.00Buy???%???%AFMDAffimed7/18/2016$2.58Outperform???%???%IONSIonis Pharmaceuticals7/18/2016$27.28$26.00Market Perform???%???%INCYIncyte7/18/2016$84.13Buy???%???%FPRXFive Prime Therapeutics7/15/2016$44.29$45.00Buy???%???%DRNADicerna Pharmaceuticals6/30/2016$3.00Buy???%???%KPTIKaryopharm Therapeutics6/27/2016$7.52Buy???%???%DAREDare Bioscience6/26/2016$2.07Buy???%???%EXELExelixis6/21/2016$7.66$10.00Outperform???%???%ARRYArray Technologies6/20/2016$3.28Buy???%???%BLUEbluebird bio6/13/2016$41.59Buy???%???%ALNYAlnylam Pharmaceuticals6/12/2016$63.17Buy???%???%QUREuniQure6/12/2016$10.73Buy???%???%KPTIKaryopharm Therapeutics6/12/2016$8.53Buy???%???%EXELExelixis6/7/2016$7.12$8.00Outperform???%???%EXELExelixis5/25/2016$6.15$8.00Outperform???%???%TRILTrillium Therapeutics5/16/2016$9.58$20.00Outperform???%???%EXELExelixis5/12/2016$5.19$8.00Buy???%???%DRNADicerna Pharmaceuticals5/10/2016$3.67Buy???%???%IONSIonis Pharmaceuticals5/5/2016$35.25$39.00Market Perform???%???%ADAPAdaptimmune Therapeutics4/24/2016$10.38Buy???%???%INCYIncyte4/18/2016$77.86Buy???%???%QUREuniQure4/13/2016$13.11$27.00Buy???%???%IONSIonis Pharmaceuticals4/9/2016$40.39Hold???%???%ADAPAdaptimmune Therapeutics4/8/2016$9.99Buy???%???%INCYIncyte4/6/2016$81.87Buy???%???%AFMDAffimed4/2/2016$4.12Buy???%???%INCYIncyte3/31/2016$72.47Buy???%???%INCYIncyte3/30/2016$69.25$85.00Outperform???%???%SYBXSynlogic3/30/2016$522.90$1,050.00Outperform???%???%ADAPAdaptimmune Therapeutics3/29/2016$7.80$23.00Outperform???%???%TRILTrillium Therapeutics3/17/2016$7.30$20.00Outperform???%???%ARQLArQule3/1/2016$1.89$2.50Market Perform???%???%INCYIncyte2/16/2016$68.36$94.00Outperform???%???%INCYIncyte2/8/2016$71.00$118.00Outperform???%???%ADAPAdaptimmune Therapeutics1/16/2016$7.66Buy???%???%DRNADicerna Pharmaceuticals12/28/2015$12.07Buy???%???%ARQLArQule12/10/2015$2.12Mkt Perform???%???%ALNYAlnylam Pharmaceuticals8/31/2015$109.07$151.00Outperform???%???%ALNYAlnylam Pharmaceuticals8/17/2015$111.45$145.00Outperform???%???%DRNADicerna Pharmaceuticals8/7/2015$11.12$30.00Outperform???%???%ADAPAdaptimmune Therapeutics7/2/2015$17.56$24.00Buy???%???%IMGNImmunoGen6/8/2015$14.70$15.00Market Perform???%???%FPRXFive Prime Therapeutics1/22/2015$24.60$35.00Outperform???%???%IMGNImmunoGen12/19/2014$10.85Market Perform???%???% Return to Analyst Rankings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access